Corvus Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2022 Dec2023 Dec2024
Assets
Assets 68.24M45.55M68.91M
Current Assets
Cash & Equivalents 13.16M12.62M8.74M
Cash & Current Investments 13.16M12.62M8.74M
Receivables - Net 0.59M0.03M0.07M
Receivables - Other 0.59M0.03M
Receivables 1.18M0.05M0.07M
Prepaid Assets 0.77M0.78M2.37M
Current Assets 43.66M27.96M54.41M
Non-Current Assets
Property, Plant & Equipment (Net) 0.35M0.24M0.15M
Long-Term Investments 21.88M16.12M12.54M
Other Non-Current Assets 0.13M0.09M0.63M
Non-Current Assets 1.65M1.43M1.32M
Liabilities
Current Liabilities
Accounts Payables 1.98M1.52M2.58M
Payables 1.98M1.52M2.58M
Accumulated Expenses 7.55M3.97M3.73M
Other Accumulated Expenses 0.16M0.24M0.29M
Current Leases 1.23M1.37M0.18M
Total Current Liabilities 10.75M6.87M35.40M
Non-Current Liabilities
Operating Leases 1.37M1.37M0.94M
Other Non-Current Liabilities 28.91M
Total Non-Current Liabilities 0.98M0.65M0.59M
Liabilities
Total Liabilities 12.12M6.87M36.34M
Shareholder's Equity
Common Equity 56.12M38.68M32.57M
Shareholder's Equity 56.12M38.68M32.57M
Liabilities and Shareholders Equity 68.24M45.55M68.91M
Retained Earnings -307.70M-334.72M-397.01M
Treasury Shares 0.40M